Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis
- 20 April 1999
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 99 (15), 2027-2033
- https://doi.org/10.1161/01.cir.99.15.2027
Abstract
Background —Angiotensin II activates NAD(P)H-dependent oxidases via AT 1 -receptor stimulation, the most important vascular source of superoxide (O 2 · − ). The AT 1 receptor is upregulated in vitro by low-density lipoprotein. The present study was designed to test whether hypercholesterolemia is associated with increased NAD(P)H-dependent vascular O 2 · − production and whether AT 1 -receptor blockade may inhibit this oxidase and in parallel improve endothelial dysfunction. Methods and Results —Vascular responses were determined by isometric tension studies, and relative rates of vascular O 2 · − production were determined by use of chemiluminescence with lucigenin, a cypridina luciferin analogue, and electron spin resonance studies. AT 1 -receptor mRNA was quantified by Northern analysis, and AT 1 -receptor density was measured by radioligand binding assays. Hypercholesterolemia was associated with impaired endothelium-dependent vasodilation and increased O 2 · − production in intact vessels. In vessel homogenates, we found a significant activation of NADH-driven O 2 · − production in both models of hyperlipidemia. Treatment of cholesterol-fed animals with the AT 1 -receptor antagonist Bay 10-6734 improved endothelial dysfunction, normalized vascular O 2 · − and NADH-oxidase activity, decreased macrophage infiltration, and reduced early plaque formation. In the setting of hypercholesterolemia, the aortic AT 1 receptor mRNA was upregulated to 166±11%, accompanied by a comparable increase in AT 1 -receptor density. Conclusions —Hypercholesterolemia is associated with AT 1 -receptor upregulation, endothelial dysfunction, and increased NADH-dependent vascular O 2 · − production. The improvement of endothelial dysfunction, inhibition of the oxidase, and reduction of early plaque formation by an AT 1 -receptor antagonist suggests a crucial role of angiotensin II–mediated O 2 · − production in the early stage of atherosclerosis.Keywords
This publication has 18 references indexed in Scilit:
- Quantification of Superoxide Radical Formation in Intact Vascular Tissue Using aCypridinaLuciferin Analog as an Alternative to LucigeninBiochemical and Biophysical Research Communications, 1998
- The Angiotensin-II Receptor Antagonist, Losartan, Inhibits LDL Lipid Peroxidation and Atherosclerosis in Apolipoprotein E-Deficient MiceBiochemical and Biophysical Research Communications, 1997
- Spin Trapping of Superoxide Radicals and Peroxynitrite by 1-Hydroxy-3-carboxy-pyrrolidine and 1-Hydroxy-2,2,6,6-tetramethyl-4-oxo-piperidine and the Stability of Corresponding Nitroxyl Radicals Towards Biological ReductantsBiochemical and Biophysical Research Communications, 1997
- Superoxide anion formation from lucigenin: an electron spin resonance spin‐trapping studyFEBS Letters, 1997
- Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug.JCI Insight, 1996
- Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.JCI Insight, 1996
- Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV.JCI Insight, 1995
- Hypercholesterolemia increases endothelial superoxide anion production.JCI Insight, 1993
- Preservation of Endothelial Function by Ramipril in Rabbits on a Long-Term Atherogenic DietJournal of Cardiovascular Pharmacology, 1991
- Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta.JCI Insight, 1990